Gedatolisib: Phase Ib data

An open-label, international Phase Ib trial in 74 patients with advanced solid tumors showed that once-weekly 90-260

Read the full 173 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE